Literature DB >> 10688818

Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.

R Letestu1, N Vitrat, A Massé, J P Le Couedic, V Lazar, P Rameau, F Wendling, J Vuillier, P Boutard, E Plouvier, M Plasse, R Favier, W Vainchenker, N Debili.   

Abstract

The thrombocytopenia and absent radii (TAR) syndrome is a rare disease associating bilateral radial agenesis and congenital thrombocytopenia. Here, we investigated in vitro megakaryocyte (MK) differentiation and expression of c-mpl in 6 patients. Using blood or marrow CD34(+) cells, the colony-forming unit (CFU)-MK number was markedly reduced. CD34(+) cells were also cultured in liquid medium in the presence of a combination of 3 cytokines (stem cell factor, interleukin-3, and interleukin-6) or megakaryocyte growth and development factor (PEG-rHuMGDF) with or without SCF. In the presence of PEG-rHuMGDF, the majority of mature megakaryocytes (CD41 high, CD42 high) underwent apoptosis. This phenomenon was also observed in cultures stimulated by three cytokines. However, this last combination of cytokines allowed a more complete terminal MK differentiation. Surprisingly, a homogeneous population of CD34(-)CD41(+)CD42(-) cells accumulated during the cultures. This population was unable to differentiate along the myeloid pathways. This result suggests that a fraction of MK cells is unable to differentiate in the TAR syndrome. We subsequently investigated whether this could be related to an abnormality in c-mpl. No mutation or rearrangement in the c-mpl gene was found by Southern blots or by sequencing of the c-mpl coding region and its promoter in any of the patients. Using Western blot analysis, a decreased level of Mpl was found in patient platelets. A decreased level of c-mpl messenger RNA in TAR platelets was also detected with a lower c-mpl-P to c-mpl-K ratio in comparison to adult platelets. Altogether, these results demonstrate that the thrombocytopenia of the TAR syndrome is associated with a dysmegakaryocytopoiesis characterized by cells blocked at an early stage of differentiation. (Blood. 2000;95:1633-1641)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688818

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome.

Authors:  Janine Fiedler; Gabriele Strauss; Martin Wannack; Silke Schwiebert; Kerstin Seidel; Katja Henning; Eva Klopocki; Markus Schmugge; Gerhard Gaedicke; Harald Schulze
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Thrombocytopenia-absent radius syndrome: a clinical genetic study.

Authors:  K L Greenhalgh; R T Howell; A Bottani; P J Ancliff; H G Brunner; C C Verschuuren-Bemelmans; E Vernon; K W Brown; R A Newbury-Ecob
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

3.  Thrombocytopaenia with absent radius (not radii).

Authors:  Uday Yanamandra; Kamal Kant Sahu; Pankaj Malhotra; Subhash Varma
Journal:  BMJ Case Rep       Date:  2014-06-02

4.  Thrombocytopenia-Absent Radius (TAR): Case report of dental implant and surgical treatment.

Authors:  Danilo-Viegas da Costa; Vania-Eloisa de Araújo; Fernando-Antônio-Mauad de Abreu; Giovanna-Ribeiro Souto
Journal:  J Clin Exp Dent       Date:  2020-12-01

5.  Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome.

Authors:  Eva Klopocki; Harald Schulze; Gabriele Strauss; Claus-Eric Ott; Judith Hall; Fabienne Trotier; Silke Fleischhauer; Lynn Greenhalgh; Ruth A Newbury-Ecob; Luitgard M Neumann; Rolf Habenicht; Rainer König; Eva Seemanova; André Megarbane; Hans-Hilger Ropers; Reinhard Ullmann; Denise Horn; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

6.  Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.

Authors:  Viola Lorenz; Haley Ramsey; Zhi-Jian Liu; Joseph Italiano; Karin Hoffmeister; Sihem Bihorel; Donald Mager; Zhongbo Hu; William B Slayton; Benjamin T Kile; Martha Sola-Visner; Francisca Ferrer-Marin
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

7.  The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.

Authors:  Thomas Mercher; Glen D Raffel; Sandra A Moore; Melanie G Cornejo; Dominique Baudry-Bluteau; Nicolas Cagnard; Jonathan L Jesneck; Yana Pikman; Dana Cullen; Ifor R Williams; Koichi Akashi; Hirokazu Shigematsu; Jean-Pierre Bourquin; Marco Giovannini; William Vainchenker; Ross L Levine; Benjamin H Lee; Olivier A Bernard; D Gary Gilliland
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 8.  Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii.

Authors:  Amy E Geddis
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 9.  Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.

Authors:  Alessandro Pecci
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

Review 10.  Inherited bone marrow failure syndromes in adolescents and young adults.

Authors:  David B Wilson; Daniel C Link; Philip J Mason; Monica Bessler
Journal:  Ann Med       Date:  2014-06-03       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.